Is depression a brain disorder? Neuroscience in mental health care

Advances in Medical Sociology

Volumn 13, Issue , 2011, Pages 123-152

  Helén, Ilpo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886402414     PISSN: 10576290     EISSN: None     Source Type: Book Series    
DOI: 10.1108/S1057-6290(2011)0000013010     Document Type: Article

References (37)

1. Andreasen, N. (2001). Brave new brain. New York, NY: Oxford University Press
2. Applbaum, K. (2006). Educating for global mental health: The adoption of SSRIs in Japan. In: A. Petryna, A. Lakoff & A. Kleinman (Eds.), Global pharmaceuticals (pp. 85-110). Durham: Duke University Press.
3. Belmaker, R. H., & Agam, G. (2008). Mechanisms of disease: Major depressive disorder. New England Journal of Medicine, 358, 55-68
4. Callahan, Ch., & Berrios, G. (2005). Reinventing depression. Oxford: Oxford University Press
5. Castel, R., Castel, F., & Lovell, A. (1982). The psychiatric society. New York: Columbia University Press
6. Castrén, E. (2005). Is mood chemistry? Nature Reviews Neuroscience, 6, 241-246 (Pubitemid 40342418)
7. Damasio, A. (1994). Descartes' error. New York: G.P. Putnam's Sons
8. Engel, J. (2008). American therapy. The rise of psychotherapy in the United States. New York: Gotham
9. Grob, G. (1991). From asylum to community. Princeton, NJ: Princeton University Press.
10. Hale, N. (1995). The rise and crisis of psychoanalysis in the United States. New York: Oxford University Press
11. Healy, D. (1997). The antidepressant era. Cambridge, MA: Harvard University Press
12. Healy, D. (2002). The creation of psychopharmacology. Cambridge, MA: Harvard University Press
13. Healy, D. (2004). Let them eat Prozac. New York: New York University Press
14. Helén, I. (2007a). Multiple depression: Making mood manageable. Journal of Medical Humanities, 28, 149-172
15. Helén, I. (2007b). Masennus massamitassa: Epidemiologinen välineistöja psykiatrian muodonmuutos. tiede & edistys, 32, 103-118
16. Helén, I. (2011). The depression paradigm and beyond. The practical ontology of mood disorders. Science Studies, 24(1), 81-112
17. Helén, I., Hämäläinen, P., & Metteri, A. (forthcoming). Komplekseja ja katkoksia - Psykiatrian hajaantuminen suomalaiseen sosiaalivaltioon. In: I. Helén (Ed.) Reformin pirstaleet. Mielenterveyspolitiikka hyvinvointivaltion jälkeen. Tampere: Vastapaino
18. Horwitz, A. (2002). Creating mental illness. Chicago: Chicago University Press
19. Horwitz, A., & Wakefield, J. (2007). The loss of sadness. Oxford: Oxford University Press
20. Kanula, S. (2008). Oireista elämänlaatuun - masennuksen markkinointi lääkäreille. Sosiologia, 45, 322-341
21. Knekt, P., & Lindfors, O. (2004). A randomized trial of the effect of four forms of psychotherapy on depressive and anxiety disorders. Design, methods, and results on the effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy during a one-year follow-up. Helsinki: Kela
22. Kramer, P. (1994). Listening to Prozac. London: Fourth Estate
23. Kramer, P. (1994). Listening to Prozac. London: Fourth Estate. Isometsä, E., Henriksson, M., Aro, H., Heikkinen, M., Kuoppasalmi, K., & Lönnqvist, J. (1994). Suicide in major depression. American Journal of Psychiatry, 151, 530-536. (Pubitemid 24115817)
24. Lönnqvist, J. (1988). National suicide prevention project in Finland: A research phase of the project. Psychiatria Fennica, 19, 125-132
25. Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3, 2011-2030 (Pubitemid 44875937)
26. Metzl, J. (2003). Prozac on the Couch. Durham: Duke University Press
27. Mol, A. (2002). The body multiple: Ontology in medical practice. Durham: Duke University Press
28. Moncrieff, J. (2009). The myth of the chemical cure (revised ed.). Houndmills: Palgrave
29. Pickersgill, M. (2010). From psyche to soma? Changing accounts of antisocial personality disorders in the American Journal of Psychiatry. History of Psychiatry, 21, 294-311
30. Pickersgill, M. (2011). 'Promising' therapies: Neuroscience, clinical practices, and the treatment of psychopathy. Sociology of Health & Illness, 33, 448-464
31. Pilgrim, D. (2002). The biopsychosocial model in Anglo-American psychiatry: Past, present and future? Journal of Mental Health, 11, 585-594 (Pubitemid 36071945)
32. Radden, J. (2003). Is this dame melancholy? Equating today's depression and past melancholia. Philosophy, Psychiatry & Psychology, 10, 37-52 (Pubitemid 37424634)
33. Rose, N. (2004). Becoming neurochemical selves. In: N. Stehr (Ed.), Biotechnology: Between commerce and civil society (pp. 89-126). New Brunswick: Transaction.
34. Rose, N. (2006). Disorders without borders? The expanding scope of psychiatric practice. BioSocieties, 1, 465-484
35. Rose, N. (2007). The politics of life itself. Princeton: Princeton University Press
36. Schildkraut, J. J., Orsulak, P., Schatzberg, A., Gudeman, J., Cole, J., Rohde, W., & LaBrie, R. (1978). Toward a biochemical classification of depressive disorders. Archives of General Psychiatry, 35, 1427-1433, 1436-1439
37. Whybrow, P., Akiskal, H., & McKinney, W. (1984). Mood disorders: Toward a new psychobiology. New York: Plenum.